NCT03213717

Brief Summary

Title: Effect of body weight loading on urinary electrolyte excretion Swedish Title: Effekt av belastning på utsöndring av elektrolyter Study period: Q2-Q3 2017 Study site: The study will be performed at the Institution for Neurology and Physiology, Sahlgrenska Academy, University of Gothenburg. Principal Investigator is John-Olov Jansson, MD, PhD, Professor at Institute of Neuroscience and Physiology, University of Gothenburg Background and study design: Weight reduction can be obtained by decreased appetite or increased metabolism. However, acute weight loss can also be obtained by loss of fluids - for example by increased urinary loss of fluid and salts, so called elctrolytes. Preliminary results from a laboratory lesson for the Master of Science in Medicine program at University of Gothenburg suggest that carrying a 10 kg weight vest could increase urinary excretion of Na+, K+ and Cl-. The purpose of this study is to investigate this further in a more controlled research setting. If confirmed, the results could potentially contribute to the development of potent diuretics or obesity medicines. The study will include 15 healthy volunteers and consist of three study days with about one week between each study day. The study subjects will go through a different study procedure each study day, and a randomized cross-over study design will be used to determine which procedure each day. Procedure 1: Wearing a weight vest with 10 % of body weight standing for seven hours. The study subject is allowed to sit for 10 minutes each hour. The reason for this is that it has been considered that the effect may be transmitted by weight loading of the lower extremities. Procedure 2: Wearing a weight vest with 1 % of body weight standing for seven hours, as a control for procedure 1, with lower loading. The study subject is allowed to sit for 10 minutes each hour. Procedure 3: Wearing a weight vest with 1 % of body weight sitting for seven hours. This is a procedure with even less loading of the lower extremities than during procedure 2. Urine- and blood samples, as well as heart rate and blood pressure measurements, will be collected during the study days and analyzed in order to address the primary and secondary objectives of the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Jun 2017

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 13, 2017

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

July 4, 2017

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 4, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 4, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 11, 2017

Completed
Last Updated

April 2, 2025

Status Verified

April 1, 2025

Enrollment Period

21 days

First QC Date

July 4, 2017

Last Update Submit

April 1, 2025

Conditions

Keywords

ObesityLoadingEdemaUrine

Outcome Measures

Primary Outcomes (1)

  • Sodium concentration

    In urine

    7 hours from start

Secondary Outcomes (17)

  • Urine Volume

    7 hours from start

  • Potassium concentration

    7 hours from start

  • Chloride concentration

    7 hours from start

  • Calcium concentration

    7 hours from start

  • Creatinine

    7 hours from start

  • +12 more secondary outcomes

Study Arms (3)

Procedure 1

EXPERIMENTAL

Wearing a weight vest with 10 % of body weight standing for seven hours. The study subject is allowed to sit for 10 minutes each hour. The reason for this is because it has been considered that the effect may be transmitted by weight loading of the lower extremities.

Other: Heavy Casall HIT weight vestBehavioral: StandingDietary Supplement: Water load

Procedure 2

ACTIVE COMPARATOR

Wearing a weight vest with 1 % of body weight standing for seven hours. The study subject is allowed to sit for 10 minutes each hour.

Behavioral: StandingDietary Supplement: Water loadOther: Light Casall HIT weight vest

Procedure 3

ACTIVE COMPARATOR

Wearing a weight vest with 1 % of body weight sitting for seven hours. This is a control group without loading of the lower extremities. This is also the normal working position for many sedentary jobs (e.g. office workers) and why this is of special interest for further investigation. There is a large body of investigative literature showing the negative health consequences of the sitting working position.

Dietary Supplement: Water loadBehavioral: SittingOther: Light Casall HIT weight vest

Interventions

A weight west with a weight of 10 % compared to the study subject

Procedure 1
StandingBEHAVIORAL

Study subjects will be standing for at least 50 minutes every hour

Procedure 1Procedure 2
Water loadDIETARY_SUPPLEMENT

Study subjects will drink 5 ml per kg body weight at the start of experiment and continue drinking the same volume as excreted by the kidneys during the experiment

Procedure 1Procedure 2Procedure 3
SittingBEHAVIORAL

Study subjects will be sitting for at least 50 minutes of every hour

Procedure 3

A weight west with a weight of 1 % compared to the study subject

Procedure 2Procedure 3

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers
  • Signed informed consent
  • Willingness to comply with study restrictions of not using alcohol, coffee etc during the hours specified below prior to each study day

You may not qualify if:

  • Subjects must not enter the study if any of the following are present:
  • Chronic disease requiring continuous medication or harden the participation in the study as judged by the investigator
  • High blood pressure (\>140/90 mm Hg)
  • Chronic pain such as pain that is constant and impairs quality of life
  • Consumption of medications during the last 7 days prior the study day, not including contraceptives
  • Consumption of nature medicine or supplements that results in a increased intake of a specific compound that isn't a nutrient during the last 7 days prior the study day
  • Smoking, snuff use or intake of drugs during the last 7 days prior the study day
  • Intake of alcohol during the last 24 hours prior the study day
  • Intake of coffee and tea during the last 12 hours prior the study day
  • Strenuous physical activity before the study during the last 6 hours prior the study day
  • Pregnancy: Females of childbearing potential must confirm to use reliable contraception and not suspect to be pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Gothenburg

Gothenburg, Box 100, S-405 30, Sweden

Location

MeSH Terms

Conditions

ObesityEdema

Interventions

Standing PositionSitting Position

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • John-Olov Jansson

    Univeristy of Gothenburg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
We will recruit healthy individuals who work at or close to the Institution of Neuroscience and Physiology at the Sahlgrenska Academy. We will ask healthy people who do not know the hypothesis of the study. Each study subject will be given a randomized code to use for the study. Only the study subject and the investigator will be able to connect each study subject with their randomized code. This will only be used under special circumstances, for example, if a study subject requests removal of his or her study data. As this study uses a cross-over design each subject will then be its own matched control. Subject eligibility will be established before enrolment and randomization. Subjects will be randomized strictly sequentially, as subjects are eligible for randomization. If a subject discontinues from the study, the subject number will not be reused, and the subject will not be allowed to re-enter the study.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: The study is executed with all 15 study subjects over three study days with one week between each study day. In order to decrease the variation of the measurement values and increase the power of the study we will use a cross-over study design. The study subjects will on one of the days wear a weight vest with 10 % of body weight in the standing position, on one of the days the same study subject will wear a weight vest with 1 % of body weight in the standing position and on one of the days the same study subject will wear a weight vest with 1 % of body weight in the sitting position. Hence, three procedures are included in the study. Each of the procedure corresponds to a separate day.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2017

First Posted

July 11, 2017

Study Start

June 13, 2017

Primary Completion

July 4, 2017

Study Completion

July 4, 2017

Last Updated

April 2, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations